Genetic Mutations Linked to Drug Resistance in Pediatric Epilepsy
Researchers studied the relationship between specific genetic variations in the SCN1A gene and resistance to sodium valproate, a common epilepsy medication, in children.
Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
Researchers studied the relationship between specific genetic variations in the SCN1A gene and resistance to sodium valproate, a common epilepsy medication, in children.
Researchers conducted a study to compare the effectiveness and safety of two medications, levetiracetam and sodium valproate, in treating children aged 1 to 16 years who were experiencing refractory generalized convulsive status epilepticus.
Researchers examined a case involving a 41-year-old man who had epilepsy and was using a vagus nerve stimulation (VNS) device to help manage his seizures.
Researchers studied a rare genetic condition called Familial Adult Myoclonic Epilepsy type 3 (FAME3), which causes seizures and tremors.
Researchers examined the use of vagus nerve stimulation (VNS) as a treatment for immune diseases, in addition to its established role in managing neurological conditions like epilepsy and depression.
Researchers examined a case involving a patient with chronic focal epilepsy, along with symptoms like upbeat nystagmus (a type of eye movement) and cerebellar ataxia (problems with coordination and balance).
Researchers studied how to better identify the areas of the brain involved in seizures using EEG data from 17 patients with drug-resistant epilepsy.
Researchers aimed to create a model that could predict when people with epilepsy might need emergency hospitalization due to recurrent seizures.
Discover how Everolimus may help children with hard-to-treat epilepsy. Stay informed about new treatment options for better seizure management.